CoChat

Withdrawal of Vioxx Casts a Shadow Over COX-2 Inhibitors

Couzin, Jennifer · 2004 · Science
Cited by 115

The DOI matches its Crossref record.

Abstract

On 30 September, the drug giant Merck announced that it was yanking its blockbuster anti- inflammation medicine, the COX-2 inhibitor Vioxx, off the market after an alarming pattern surfaced halfway through a 3-year colon polyp prevention study. Heart attacks and strokes had occurred at a much higher rate among the roughly 1300 volunteers on Vioxx (3.5%) than among the 1300 taking a placebo (1.9%). Within days, pharmacies were packing up their supplies of Vioxx and shipping them back to the company.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.306.5695.384

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 115

Metadata

Authors
Couzin, J.
Venue
Science
Published
2004-10-15
Volume
306
Issue
5695
Pages
384-385
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W1555254253
Cited by
115
References
0
Type
other
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Withdrawal of Vioxx Casts a Shadow Over COX-2 Inhibitors. https://app.cochat.ai/papers/10.1126/science.306.5695.384
The paper
Couzin, J. (2004). Withdrawal of Vioxx Casts a Shadow Over COX-2 Inhibitors. Science. https://doi.org/10.1126/science.306.5695.384

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.